Abstract
Purpose
Keloids are benign dermal tumors that arise from abnormal wound healing processes following skin lesions. Surgical excision followed by radiotherapy plays an important role in the treatment of keloids. Nevertheless, radioresistance remains a serious impediment to treatment efficacy. Investigation of the molecular response of keloids to radiation may contribute to radiosensitizing strategies.
Materials and methods
Primary keloid fibroblasts from human keloids were isolated and irradiated with X-ray. The expression profiles of messenger RNA (mRNA) in nonradiated and irradiated primary keloid fibroblasts were measured by mRNA sequencing analysis. Then, we identified common motifs and corresponding transcription factors of dysregulated mRNAs by using bioinformatic analysis of the proximal promoters. Whereafter, GO and KEGG were used to analyze the functional enrichment of the differentially expressed genes.
Results
We found that radiation not only suppressed proliferation but also increased cell senescence of primary keloid fibroblasts. There were 184 mRNAs and 204 mRNAs that showed significant changes in 4 and 8 Gy irradiated primary keloid fibroblasts, respectively. Among them, 8 upregulated and 30 downregulated mRNAs showed consistent alterations in 4 and 8 Gy irradiated primary keloid fibroblasts. More importantly, the xForkhead box O1 (FOXO1) signaling pathway was involved in the irradiation response. Pretreatment with the FOXO1 signaling inhibitor AS1842856 significantly promoted LDH release, apoptosis and senescence of primary keloid fibroblasts following irradiation.
Conclusion
Our findings illustrated the molecular changes in human keloid fibroblasts in response to radiation, and FOXO1 pathway inhibition is expected to provide a novel strategy for the radiosensitization of keloids.
Author contributions
MH and XL conceived the experiments and designed the research. MH, XL, YL and WM performed the molecular biology experiments. SC, TY and YS analyzed and interpreted the data. DY provided general supervision. DY and SZ performed statistical analysis. SZ performed manuscript editing. All authors have read and approved the final manuscript.
Disclosure statement
The authors have no conflicting interests.
Additional information
Funding
Notes on contributors
Min Hong
Min Hong is a Research Scientist in Laboratory of Radiation Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, China. She is currently working in Qingdao Municipal Center for Disease Control and Prevention of Qingdao, Qingdao, Institute of Preventive Medicine, Qingdao, 266034, Shandong, China.
Xiaoqian Li
Xiaoqian Li is a Student of West China School of Basic Medical Sciences and Forensic Medicine, which belongs to Sichuan University. The lab, which she studied, belongs to West China Second University Hospital and West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University.
Yulan Liu
Yulan Liu is a Doctor of Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital.
Wei Mo
Wei Mo is a Postgraduate of State Key Lab of Radiation Medicine and Protection and School of Radiation Medicine and Protection, which belongs to Medical College of Soochow University.
Bin Shi
Bin Shi is a Student of West China School of Basic Medical Sciences and Forensic Medicine, which belongs to Sichuan University. The lab, which he studied, belongs to West China Second University Hospital and West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University.
Shigao Chen
Shigao Chen is a Doctor of Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital.
Tao Yan
Tao Yan is a Junior Research Assistant at West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University.
Yuhong Shi
Yuhong Shi is a Doctor of Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital.
Daojiang Yu
Daojiang Yu, Ph.D., Medical Director of Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital. He is a doctoral candidate at West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University.
Shuyu Zhang
Shuyu Zhang, Ph.D., is Head of the Lab of Radiation Medicine, which both belongs to West China Second University Hospital and West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University. Moreover, He is a Senior Researcher at Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital.